PMC:7600245 / 57262-57382 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T249","span":{"begin":91,"end":100},"obj":"Disease"}],"attributes":[{"id":"A249","pred":"mondo_id","subj":"T249","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Furthermore, in vitro studies demonstrated a specific inhibitory activity against MERS-CoV infection by sirolimus [184]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T577","span":{"begin":43,"end":44},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T578","span":{"begin":65,"end":73},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Furthermore, in vitro studies demonstrated a specific inhibitory activity against MERS-CoV infection by sirolimus [184]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T42004","span":{"begin":104,"end":113},"obj":"Chemical"}],"attributes":[{"id":"A44463","pred":"chebi_id","subj":"T42004","obj":"http://purl.obolibrary.org/obo/CHEBI_9168"}],"text":"Furthermore, in vitro studies demonstrated a specific inhibitory activity against MERS-CoV infection by sirolimus [184]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T432","span":{"begin":0,"end":120},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Furthermore, in vitro studies demonstrated a specific inhibitory activity against MERS-CoV infection by sirolimus [184]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1782","span":{"begin":104,"end":113},"obj":"Chemical"},{"id":"1789","span":{"begin":87,"end":100},"obj":"Disease"}],"attributes":[{"id":"A1782","pred":"tao:has_database_id","subj":"1782","obj":"MESH:D020123"},{"id":"A1789","pred":"tao:has_database_id","subj":"1789","obj":"MESH:D018352"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Furthermore, in vitro studies demonstrated a specific inhibitory activity against MERS-CoV infection by sirolimus [184]."}